DATIROS Trademark

Trademark Overview

On Tuesday, December 1, 2020, a trademark application was filed for DATIROS with the United States Patent and Trademark Office. The USPTO has given the DATIROS trademark a serial number of 90351478. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 23, 2024. This trademark is owned by Basilea Pharmaceutica AG. The DATIROS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases
datiros

General Information

Serial Number90351478
Word MarkDATIROS
Filing DateTuesday, December 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, for the treatment of dermatological disorders, for the treatment of oncological diseases, for the treatment of gastrointestinal diseases, for the treatment of neurological diseases, for the treatment of cardiovascular diseases, and for the treatment of gynecological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBasilea Pharmaceutica AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Trademark Events

Event DateEvent Description
Friday, December 4, 2020NEW APPLICATION ENTERED
Friday, February 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 18, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 22, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 22, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 28, 2022SOU EXTENSION 1 FILED
Friday, January 28, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 2, 2022SOU EXTENSION 2 FILED
Tuesday, August 2, 2022SOU EXTENSION 2 GRANTED
Thursday, August 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 19, 2023SOU EXTENSION 3 FILED
Thursday, January 19, 2023SOU EXTENSION 3 GRANTED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 8, 2023SOU EXTENSION 4 FILED
Tuesday, August 8, 2023SOU EXTENSION 4 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 5 GRANTED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 5 FILED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 23, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

datiros treatment diseases gastrointestinal neurological oncological cardiovascular gynecological dermatological preparations substances